CARDIOVASCULAR EFFECTS OF SU-4885 (MEPYRAPONE), AN INHIBITOR OF CORTICOSTEROID BIOSYNTHESIS.
D000305:Adrenal Cortex Hormones; D000309:Adrenal Insufficiency; D000889:Anti-Arrhythmia Agents; D001011:Aorta; D001783:Blood Flow Velocity; D001794:Blood Pressure; D002415:Cats; D004285:Dogs; D006321:Heart; D006854:Hydrocortisone; D007659:Ketones; D008660:Metabolism; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010600:Pharmacology; D012106:Research
D000305:Adrenal Cortex Hormones; D000889:Anti-Arrhythmia Agents; D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D006854:Hydrocortisone; D008797:Metyrapone
ADRENAL GLAND HYPOFUNCTION; ALDOSTERONE ANTAGONISTS; AORTA; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CATS; DOGS; EXPERIMENTAL LAB STUDY; HEART; HYDROCORTISONE; KETONES; METABOLISM; METYRAPONE; MYOCARDIAL DEPRESSANTS; PHARMACOLOGY